• Skip to main content
  • Skip to footer
Eco Friendly CBD OIL

Eco Friendly CBD OIL

The Best Eco Friendly CBD Oil

  • Home
  • CBD Health
  • Cannabis News
  • Contact

CBD OIL

Indiana Representative Introduces Adult-Use Cannabis Legalization Bill

February 5, 2021 by CBD OIL

After a failed attempt to legalize adult-use cannabis last year, the New Mexico Legislature is once again taking up the issue, this time placing a greater emphasis on social equity.

RELATED: New Mexico Lawmakers Introduce Competing Adult-Use Cannabis Legalization Proposals

Four legalization bills have been introduced in the legislature to date—two in the Senate and two in the House. Lawmakers are essentially considering three different versions of legalization proposals, as one of the Senate bills is identical to the House version.

“They all have some similarities, but there’s really only one that truly centers [on] equity and social justice, and that is of critical importance to Drug Policy Alliance, but even more so to the communities in New Mexico that have been harmed by prohibitionist policies,” Emily Kaltenbach, senior director of resident states and New Mexico for Drug Policy Alliance, told Cannabis Business Times and Cannabis Dispensary.

That bill, Kaltenbach said, is House Bill 12, sponsored by Reps. Javier Martinez and Andrea Romero.

“Rep. Martinez has been working on this issue for years,” Kaltenbach said. “He strongly believes that social justice and equity have to be the foundations of a legalization bill. Obviously, we want whatever bill gets through and gets to the governor’s desk to center [on] social justice and equity, and that’s what we’ll be fighting for this session.”

H.B. 12 aims to create diversity in businesses through a microbusiness license type, which would grant companies a head start in the adult-use program, alongside the state’s existing medical cannabis licensees. These licenses would then be scaled, based on the size and type, so that microbusinesses pay less in licensing fees than larger companies.

“In a state like New Mexico, that’s really important because we have a lot of family farms that we’d like to see flourish under a new industry,” Kaltenbach said. “We want to make sure that small businesses have a point of entry into the new industry, where they don’t have to come in with as much capital to participate. So, those licensing provisions are really key and critical.”

The legislation would also require adult-use cannabis operators to develop an equity plan for their businesses, and those with past cannabis-related convictions could not be barred from participating in the industry solely based on that conviction.

In addition, the bill includes provisions that would not only automatically expunge past cannabis-related convictions but would also resentence those who are currently serving time for such crimes.

H.B. 12 also allows for the home cultivation of cannabis and includes language that would protect medical cannabis patients and adult-use consumers from being denied public benefits or health care based on a positive cannabis drug test.

The legislation would also prevent children from being taken from their families, as well as prevent parents from being denied custodial or visitation rights, solely based on the use of cannabis.

The measure would invest funds generated from adult-use cannabis tax revenue back into the communities most impacted by prohibition. The bill calls for a Community Reinvestment Fund, where 35% of excise tax revenue would support qualifying communities.

While Drug Policy Alliance is supportive of all of these provisions, Kaltenbach said the organization would like to see the bill go further in addressing how the state’s tribal nations can participate in an adult-use cannabis market.

“I think that’s really important in a state like New Mexico, where we do have so many sovereign nations, making sure that the nations and tribes also are participating,” she said.

The organization would also like to see more innovative license types, Kaltenbach added, such as a co-op license that would allow local communities to own some of the licenses.

The New Mexico Legislature is just about halfway through its 60-day legislative session, but Kaltenbach believes the cannabis legalization proposals will start moving in the next week or so.

“Time is definitely not on our side, but we’re going to be working hard,” she said.

H.B. 12’s first stop is the House Health and Human Services Committee, which could take up the bill as soon as next week, and then the legislation will go to the House Tax Committee before it moves to the Senate for consideration.

“I believe that we’ll see a lot of negotiations, since there are four different bills, and this is a priority … to see how all of these measures come together, so we can get it to the governor’s desk,” Kaltenbach said. “I think once the House bill moves over to the Senate and the Senate starts hearing those bills, we’ll see the pace pick up.”

Although adult-use legalization has stalled in the past, Kaltenbach said the odds of meaningful policy reform seem better this year, as long as some key disagreements can be resolved.

First and foremost, she said, is the issue of plant counts and whether licensed cultivators should be able to grow a limited or unlimited number of plants in the adult-use program, an issue that has long been contested in New Mexico’s medical program.

“I really think it depends on whether everyone can come to the table and agree on the core provisions and, obviously, whatever bill moves forward, in our opinion, it must center [on] equity and social justice,” Kaltenbach said. “If it doesn’t, it’s a nonstarter for us.”

Filed Under: Cannabis News

California Cannabis Authorities Receive Approval for Regulations to Facilitate Financial Services for Cannabis Businesses

February 5, 2021 by CBD OIL

Willie Nelson’s cannabis brand, Willie’s Reserve, has hit the Arizona market through a recently announced partnership with Hana Meds, an Arizona-based vertically integrated cannabis company.

Willie’s Reserve is a national cannabis brand inspired by cannabis activist and American music legend Willie Nelson. The brand focuses on various cannabis products like pre-rolls, flower, vape cartridges and more. 

Hana Meds is processing, packaging and distributing Willie’s Reserve pre-rolls across Hana Meds’ retail locations in Kingman and Green Valley, Ariz., and at its wholesale customer locations, Giving Tree Dispensary in Phoenix and MedMen Scottsdale, said Matt Pinchera, Hana Meds president.

“We are starting off with launching pre-rolls only, and then we’ll look at other products as it makes sense,” he said. “We definitely want to expand the product line, but right now, we’re focusing on the pre-rolls first.”

Hana Meds eventually hopes to expand the number of dispensaries the product is sold in, he said.

Courtesy of Hana Meds

Pinchera

“We are in the process of ramping up production, so, hopefully, we’ll be able to expand the wholesale customers as we expand our production capabilities,” he said. “We’ve got two dispensaries who partnered with us to launch the brand and want to make sure that we keep them in stock of a product. So, you know, we don’t want to expand too quickly. It really needs to be tied to our production increases.”

Aside from Hana Meds’ already established in-house brands, like Dutchie pre-rolls and Revival Infused Edibles, Pinchera said that Hana Meds also looks to partner with companies that acquire brands that Hana Meds feels will do well in the Arizona market. Willie’s Reserve fit the bill.

So, how did the official partnership happen?

Hana Meds met Willie’s Reserve team members at a conference in 2019, where they started to explore the partnership option and discuss Hana Meds’ capabilities.

“Because we already produce a pre-roll brand, we have the infrastructure in place to produce pre-rolls, which is what they wanted to enter the market with,” he said. “So, that lined up for them and for us. I also think the fact that we were in the process of expanding our production, which means we would be able to supply more products for Willie’s Reserve in the future, was also a positive in their eyes, from what we brought to the table.”

Pinchera believes that if a cannabis business is looking to partner with a national brand in a local market, it’s essential to highlight their own skills and growth capabilities.

“I think you need to focus on your capabilities, focus on what you do well; for us, it was producing pre-rolls with our Dutchie brand,” he said. “Secondly, anticipate growth and work on expanding production and cultivation. You really just have to leverage what you do well and make sure you have the capacity for increased production.”

For example, as Hana Meds started conversing with Willie’s Reserve, it began to expand its production facilities to ensure it could handle the increased pre-roll production, which was done to ensure Willie’s Reserve needs are met and to try and attract other brands that Hana Meds wanted to partner with, he said.

Alongside production expansion, Hana Meds also wants to consistently put a quality product out under the Willie’s Reserve name.

“The cannabis has to be high quality, which we’ve had a lot of success with our Dutchie brand,” he said. “Our wholesale customers and medical patient customers up until now have found our cannabis to be of high quality. That was certainly something that Willie’s demanded and that’s something that we’ve been producing, and we’re able to offer up to them.”

Hana Meds and Willie’s Reserve share similar values. They are dedicated to producing high-quality cannabis products, which leads Pinchera to believe that this will be a continuing partnership.

“Because they have a solid marketing department, utilizing both social media and traditional media, and because they have Willie Nelson as a brand ambassador, that has been a huge positive for us,” he said. “And I think the partnership will continue to be a huge positive for us moving forward. Willie’s Reserve has a lot to bring to the table, and they’re a great company to partner with.”

 

Filed Under: Cannabis News

New Mexico Lawmakers Consider Social Equity in Cannabis Legalization Proposals

February 5, 2021 by CBD OIL

After a failed attempt to legalize adult-use cannabis last year, the New Mexico Legislature is once again taking up the issue, this time placing a greater emphasis on social equity.

RELATED: New Mexico Lawmakers Introduce Competing Adult-Use Cannabis Legalization Proposals

Four legalization bills have been introduced in the legislature to date—two in the Senate and two in the House. Lawmakers are essentially considering three different versions of legalization proposals, as one of the Senate bills is identical to the House version.

“They all have some similarities, but there’s really only one that truly centers [on] equity and social justice, and that is of critical importance to Drug Policy Alliance, but even more so to the communities in New Mexico that have been harmed by prohibitionist policies,” Emily Kaltenbach, senior director of resident states and New Mexico for Drug Policy Alliance, told Cannabis Business Times and Cannabis Dispensary.

That bill, Kaltenbach said, is House Bill 12, sponsored by Reps. Javier Martinez and Andrea Romero.

“Rep. Martinez has been working on this issue for years,” Kaltenbach said. “He strongly believes that social justice and equity have to be the foundations of a legalization bill. Obviously, we want whatever bill gets through and gets to the governor’s desk to center [on] social justice and equity, and that’s what we’ll be fighting for this session.”

H.B. 12 aims to create diversity in businesses through a microbusiness license type, which would grant companies a head start in the adult-use program, alongside the state’s existing medical cannabis licensees. These licenses would then be scaled, based on the size and type, so that microbusinesses pay less in licensing fees than larger companies.

“In a state like New Mexico, that’s really important because we have a lot of family farms that we’d like to see flourish under a new industry,” Kaltenbach said. “We want to make sure that small businesses have a point of entry into the new industry, where they don’t have to come in with as much capital to participate. So, those licensing provisions are really key and critical.”

The legislation would also require adult-use cannabis operators to develop an equity plan for their businesses, and those with past cannabis-related convictions could not be barred from participating in the industry solely based on that conviction.

In addition, the bill includes provisions that would not only automatically expunge past cannabis-related convictions but would also resentence those who are currently serving time for such crimes.

H.B. 12 also allows for the home cultivation of cannabis and includes language that would protect medical cannabis patients and adult-use consumers from being denied public benefits or health care based on a positive cannabis drug test.

The legislation would also prevent children from being taken from their families, as well as prevent parents from being denied custodial or visitation rights, solely based on the use of cannabis.

The measure would invest funds generated from adult-use cannabis tax revenue back into the communities most impacted by prohibition. The bill calls for a Community Reinvestment Fund, where 35% of excise tax revenue would support qualifying communities.

While Drug Policy Alliance is supportive of all of these provisions, Kaltenbach said the organization would like to see the bill go further in addressing how the state’s tribal nations can participate in an adult-use cannabis market.

“I think that’s really important in a state like New Mexico, where we do have so many sovereign nations, making sure that the nations and tribes also are participating,” she said.

The organization would also like to see more innovative license types, Kaltenbach added, such as a co-op license that would allow local communities to own some of the licenses.

The New Mexico Legislature is just about halfway through its 60-day legislative session, but Kaltenbach believes the cannabis legalization proposals will start moving in the next week or so.

“Time is definitely not on our side, but we’re going to be working hard,” she said.

H.B. 12’s first stop is the House Health and Human Services Committee, which could take up the bill as soon as next week, and then the legislation will go to the House Tax Committee before it moves to the Senate for consideration.

“I believe that we’ll see a lot of negotiations, since there are four different bills, and this is a priority … to see how all of these measures come together, so we can get it to the governor’s desk,” Kaltenbach said. “I think once the House bill moves over to the Senate and the Senate starts hearing those bills, we’ll see the pace pick up.”

Although adult-use legalization has stalled in the past, Kaltenbach said the odds of meaningful policy reform seem better this year, as long as some key disagreements can be resolved.

First and foremost, she said, is the issue of plant counts and whether licensed cultivators should be able to grow a limited or unlimited number of plants in the adult-use program, an issue that has long been contested in New Mexico’s medical program.

“I really think it depends on whether everyone can come to the table and agree on the core provisions and, obviously, whatever bill moves forward, in our opinion, it must center [on] equity and social justice,” Kaltenbach said. “If it doesn’t, it’s a nonstarter for us.”

Filed Under: Cannabis News

Pennsylvania Governor Includes Adult-Use Cannabis Legalization in State Budget Proposal

February 5, 2021 by CBD OIL

Willie Nelson’s cannabis brand, Willie’s Reserve, has hit the Arizona market through a recently announced partnership with Hana Meds, an Arizona-based vertically integrated cannabis company.

Willie’s Reserve is a national cannabis brand inspired by cannabis activist and American music legend Willie Nelson. The brand focuses on various cannabis products like pre-rolls, flower, vape cartridges and more. 

Hana Meds is processing, packaging and distributing Willie’s Reserve pre-rolls across Hana Meds’ retail locations in Kingman and Green Valley, Ariz., and at its wholesale customer locations, Giving Tree Dispensary in Phoenix and MedMen Scottsdale, said Matt Pinchera, Hana Meds president.

“We are starting off with launching pre-rolls only, and then we’ll look at other products as it makes sense,” he said. “We definitely want to expand the product line, but right now, we’re focusing on the pre-rolls first.”

Hana Meds eventually hopes to expand the number of dispensaries the product is sold in, he said.

Courtesy of Hana Meds

Pinchera

“We are in the process of ramping up production, so, hopefully, we’ll be able to expand the wholesale customers as we expand our production capabilities,” he said. “We’ve got two dispensaries who partnered with us to launch the brand and want to make sure that we keep them in stock of a product. So, you know, we don’t want to expand too quickly. It really needs to be tied to our production increases.”

Aside from Hana Meds’ already established in-house brands, like Dutchie pre-rolls and Revival Infused Edibles, Pinchera said that Hana Meds also looks to partner with companies that acquire brands that Hana Meds feels will do well in the Arizona market. Willie’s Reserve fit the bill.

So, how did the official partnership happen?

Hana Meds met Willie’s Reserve team members at a conference in 2019, where they started to explore the partnership option and discuss Hana Meds’ capabilities.

“Because we already produce a pre-roll brand, we have the infrastructure in place to produce pre-rolls, which is what they wanted to enter the market with,” he said. “So, that lined up for them and for us. I also think the fact that we were in the process of expanding our production, which means we would be able to supply more products for Willie’s Reserve in the future, was also a positive in their eyes, from what we brought to the table.”

Pinchera believes that if a cannabis business is looking to partner with a national brand in a local market, it’s essential to highlight their own skills and growth capabilities.

“I think you need to focus on your capabilities, focus on what you do well; for us, it was producing pre-rolls with our Dutchie brand,” he said. “Secondly, anticipate growth and work on expanding production and cultivation. You really just have to leverage what you do well and make sure you have the capacity for increased production.”

For example, as Hana Meds started conversing with Willie’s Reserve, it began to expand its production facilities to ensure it could handle the increased pre-roll production, which was done to ensure Willie’s Reserve needs are met and to try and attract other brands that Hana Meds wanted to partner with, he said.

Alongside production expansion, Hana Meds also wants to consistently put a quality product out under the Willie’s Reserve name.

“The cannabis has to be high quality, which we’ve had a lot of success with our Dutchie brand,” he said. “Our wholesale customers and medical patient customers up until now have found our cannabis to be of high quality. That was certainly something that Willie’s demanded and that’s something that we’ve been producing, and we’re able to offer up to them.”

Hana Meds and Willie’s Reserve share similar values. They are dedicated to producing high-quality cannabis products, which leads Pinchera to believe that this will be a continuing partnership.

“Because they have a solid marketing department, utilizing both social media and traditional media, and because they have Willie Nelson as a brand ambassador, that has been a huge positive for us,” he said. “And I think the partnership will continue to be a huge positive for us moving forward. Willie’s Reserve has a lot to bring to the table, and they’re a great company to partner with.”

 

Filed Under: Cannabis News

Illinois Lawmaker Renews Push to Create New Cannabis Retail Licenses

February 5, 2021 by CBD OIL

Willie Nelson’s cannabis brand, Willie’s Reserve, has hit the Arizona market through a recently announced partnership with Hana Meds, an Arizona-based vertically integrated cannabis company.

Willie’s Reserve is a national cannabis brand inspired by cannabis activist and American music legend Willie Nelson. The brand focuses on various cannabis products like pre-rolls, flower, vape cartridges and more. 

Hana Meds is processing, packaging and distributing Willie’s Reserve pre-rolls across Hana Meds’ retail locations in Kingman and Green Valley, Ariz., and at its wholesale customer locations, Giving Tree Dispensary in Phoenix and MedMen Scottsdale, said Matt Pinchera, Hana Meds president.

“We are starting off with launching pre-rolls only, and then we’ll look at other products as it makes sense,” he said. “We definitely want to expand the product line, but right now, we’re focusing on the pre-rolls first.”

Hana Meds eventually hopes to expand the number of dispensaries the product is sold in, he said.

Courtesy of Hana Meds

Pinchera

“We are in the process of ramping up production, so, hopefully, we’ll be able to expand the wholesale customers as we expand our production capabilities,” he said. “We’ve got two dispensaries who partnered with us to launch the brand and want to make sure that we keep them in stock of a product. So, you know, we don’t want to expand too quickly. It really needs to be tied to our production increases.”

Aside from Hana Meds’ already established in-house brands, like Dutchie pre-rolls and Revival Infused Edibles, Pinchera said that Hana Meds also looks to partner with companies that acquire brands that Hana Meds feels will do well in the Arizona market. Willie’s Reserve fit the bill.

So, how did the official partnership happen?

Hana Meds met Willie’s Reserve team members at a conference in 2019, where they started to explore the partnership option and discuss Hana Meds’ capabilities.

“Because we already produce a pre-roll brand, we have the infrastructure in place to produce pre-rolls, which is what they wanted to enter the market with,” he said. “So, that lined up for them and for us. I also think the fact that we were in the process of expanding our production, which means we would be able to supply more products for Willie’s Reserve in the future, was also a positive in their eyes, from what we brought to the table.”

Pinchera believes that if a cannabis business is looking to partner with a national brand in a local market, it’s essential to highlight their own skills and growth capabilities.

“I think you need to focus on your capabilities, focus on what you do well; for us, it was producing pre-rolls with our Dutchie brand,” he said. “Secondly, anticipate growth and work on expanding production and cultivation. You really just have to leverage what you do well and make sure you have the capacity for increased production.”

For example, as Hana Meds started conversing with Willie’s Reserve, it began to expand its production facilities to ensure it could handle the increased pre-roll production, which was done to ensure Willie’s Reserve needs are met and to try and attract other brands that Hana Meds wanted to partner with, he said.

Alongside production expansion, Hana Meds also wants to consistently put a quality product out under the Willie’s Reserve name.

“The cannabis has to be high quality, which we’ve had a lot of success with our Dutchie brand,” he said. “Our wholesale customers and medical patient customers up until now have found our cannabis to be of high quality. That was certainly something that Willie’s demanded and that’s something that we’ve been producing, and we’re able to offer up to them.”

Hana Meds and Willie’s Reserve share similar values. They are dedicated to producing high-quality cannabis products, which leads Pinchera to believe that this will be a continuing partnership.

“Because they have a solid marketing department, utilizing both social media and traditional media, and because they have Willie Nelson as a brand ambassador, that has been a huge positive for us,” he said. “And I think the partnership will continue to be a huge positive for us moving forward. Willie’s Reserve has a lot to bring to the table, and they’re a great company to partner with.”

 

Filed Under: Cannabis News

Cannabicitran & Cannabitriol: What’s the Deal?

February 4, 2021 by CBD OIL

Researchers are starting to develop a better grasp on cannabidiol (CBD) and delta-9 tetrahydrocannabinol (THC), but this only scratches the surface of the known phytocannabinoids.

The lack of concrete knowledge on CBD and THC, including its ability to treat certain conditions, results from major discoveries in cannabis during the last few decades due to federal prohibition and research restrictions.

However, the industry is now taking a closer look at other cannabinoids in the plant to see what powers they might hold. Here we discuss just two of these beginning to make waves.

Cannabitriol

Cannabitriol (CBT) is a cannabinoid first isolated in 1968. And a study has shown that it is a major product of THC oxidative degradation.[1]

CBT is much less common in cannabis in comparison to THC and CBD, and therefore, it is considered a rare minor cannabinoid. While there is very little known about its therapeutic effects, a very early pre-clinical study showed that it could have potential to treat glaucoma.[2]

Cannabicitran

Cannabicitran (CBT-C5) is also a minor cannabinoid that is often confused with CBT but is a unique cannabinoid in its own right. There is very little known about this cannabinoid but that could quickly change.

Currently, GVB Biopharma is looking into CBT-C to delve further into its potential benefits.

The aforementioned studies have not established concrete findings on either of these cannabinoids. Research is still in the preliminary phase and much remains undiscovered. Much like other phytocannabinoid and their derivatives, academic data on the matter has a long way to go before any tangible conclusions can be made.

But these highlight the exciting state of cannabinoid research. Every day, new findings are published and we get closer and closer to a better understanding of the compounds in this magical plant.

Image Credit: Photo Mix

Image Source: https://pixabay.com/photos/experiment-research-laboratory-5607399/

References

  1. Brogan AP, et al. Antibody-catalyzed oxidation of Δ9-tetrahydrocannabinol. Journal of the American Chemical Society. 2007;129(12):3698-3702.
  2. Elsohly MA, et al. (1984) Cannabinoids in glaucoma II: The effect of different cannabinoids on intraocular pressure of the rabbit. Current Eye Research. 1984;3(6):841-850.

Filed Under: CBD Health

How Does Genetics Affect THC:CBD Ratios?

February 4, 2021 by CBD OIL

Phytocannabinoid composition in a cannabis cultivar determines most of its benefits. This makes the tetrahydrocannabinol (THC) to cannabidiol (CBD) ratio a matter of great significance for scientists, clinicians, and consumers alike, as these major cannabinoids provide different effects.

Phytocananbinoids do not work in isolation. When they come together in a cultivar, they create an opportunity for ensemble benefits. Thus, phytocannabinoid composition is one of the most important aspects of any cultivar.

A group of researchers from the University of Minnesota recently set out to investigate the role that genetic variation plays in influencing cannabinoid ratios.[1]

Study Overview

The researchers employed a Drug Enforcement Administration (DEA)-approved research protocol to study feral C. sativa that was obtained from the Minnesota River Valley. Minnesota is in fact the first place CBD was isolated from feral hemp, making it an interesting place to study genetic variations.

Authors categorized THC:CBD ratios as THC-type, CBD-type, and intermediate type. In this study, a genetic model was created to examine the relationship between phytocannabinoid ratios with functional and non-functional alleles of the gene cannabidiolic acid synthase gene (CBDAS).

Methods

The researchers analyzed the CBDAS genotypes of over 300 feral cultivars; in addition, 20 “clinical” cultivars from the National Institute on Drug Abuse and 12 Canadian-certified grain cultivars were included to validate the model.

The samples were analyzed and gas chromatography methods were used to measure the levels of phytocannabinoids present, including cannabichromene (CBC), cannabigerol (CBG), CBD, THC, cannabinol (CBN), delta‐8‐THC, and tetrahydrocannabivarin (THCV). Genotypes were used to predict THC:CBD ratios.

Results

The researchers found a direct correlation (predicted with 100% accuracy) between the CBDAS genotypes and the cannabinoid content in the feral cultivars, even though the total phytocannabinoid content varied substantially. Similar results were obtained from the “clinical” and industrial cultivars.[1]

These findings add further evidence that the industry at large should drop the nomenclature differentiating cannabinoids from cannabis vs. hemp or referring to certain cultivars as industrial, clinical, or feral.

This small study indicates that CBDAS genotypes may be used to predict cannabinoid profiles in a cultivar.

Image Credit: Pete Linforth

Image Source: https://pixabay.com/illustrations/dna-genetics-biology-science-3889611/

Reference

  1. Wenger, Jonathan P. et al. Validating a predictive model of cannabinoid inheritance with feral, clinical, and industrial Cannabis sativa. American Journal of Botany. 2020;107(10): 1423-1432.

Filed Under: CBD Health

CBD & Anxiety: R&D Underway for New Treatment

February 4, 2021 by CBD OIL

With traditional anxiety medications such as benzodiazepines being highly addictive, there’s been a keen interest in using cannabidiol (CBD) to treat the mental health condition. And there’s a clear need for better treatments, as anxiety currently plagues 18.1% of adults in the US (40 million people). That number has soared over the past year due to the COVID-19 pandemic.

There are two challenges in getting CBD approved for anxiety treatment: a lack of sufficient clinical research into the effects of CBD on anxiety and thus lack of Food and Drug Administration (FDA) approval, and lack of quality and standardization of CBD products currently on the market. Luckily many researchers are looking to solve these issues by conducting proper studies.

Empower Pharm is a Canadian pharmaceutical company that wants to help those seeking cannabinoid treatment for a number of ailments, including anxiety. A Phase I clinical trial is currently in the works to evaluate out how a synthetic CBD tablet (Empower CBDTM) might help those combatting anxiety.

Aubrey Dan, co-founder and executive chairman of EmpowerPharm, believes that synthetic cannabinoids have the potential to relieve a variety of health issues. By preparing synthetic CBD into an active pharmaceutical ingredient (API), they seek to develop a product that is 99.9% pure.

This would differ greatly from products currently available, as most contain a smaller percentage of CBD. For example, Dan explained, the average CBD oil has between 65% to 80% total cannabinoids. Additionally, EmpowerPharm aims to remove all traces of tetrahydrocannabinol (THC).

A lack of THC is ideal for anxiety, as some individuals have reported it can actually cause anxiety depending on the dose.

EmpowerPharm was able to source a synthesized CBD API that’s been GMP-approved by Health Canada and the FDA. Within the next few months, Health Canada is expected to perform an inspection and, if things go as planned, Dan and his team will begin their Phase I clinical trial.

Empower Pharm hopes to find significant evidence that this formulation can be used as a safe and effective CBD pharmaceutical for anxiety.

Image Credit: Hal Gatewood

Image Source: https://unsplash.com/photos/_jbClosDsD4

Filed Under: CBD Health

CBD & Oral Health: What Does the Research Say?

February 4, 2021 by CBD OIL

Taking care of our teeth typically requires regular dentists visits and keeping some toothpaste and floss handy. But some research suggests that we may also want to consider adding cannabidiol (CBD) to our repertoire of oral care products.

Gum Disease

Gum disease–otherwise known as periodontitis–is a type of infection that can cause harm to the soft tissues in the mouth. If not treated in a timely and appropriate manner, it can damage bones. Periodontitis can lead to tooth loss.

Pre-clinical research has linked CBD to anti-inflammatory effects; in fact, the cannabinoid may help prevent significant inflammation of the gums and help slow tooth loss.[1]

Plaque

Proper oral care involves fighting tooth decay and cavities, both of which can be caused by the buildup of plaque on the teeth. Plaque can develop when food remnants are left on the teeth for a long time. Certain foods can accelerate this process, such as carbohydrates.

Bacteria can thrive in the mouth as a result of the presence of plaque, which can inevitably lead to the production of acids. Acids can damage enamel and may lead to cavities and gingivitis. Brushing with toothpaste and flossing every day can help remove plaque from teeth. But aside from the conventional fluoride-based toothpaste products on the market, CBD may also play a role in getting rid of plaque.

In one small study, dental plaque was collected from participants and treated with various substances, including CBD. Compared to traditional toothpaste, CBD and cannabinoids were shown to rival common oral products in terms of keeping plaque at bay.[2]

Tooth Sensitivity

Tooth sensitivity may not always require a pain reliever to alleviate discomfort, depending on severity. Instead, CBD may help to calm tooth sensitivity to hot or cold. The cannabinoid has been shown to reduce pain by interacting with endocannabinoid receptors and calming inflammation that can contribute to tooth pain.[3]

CBD appears to play a potential beneficial role in oral health, pending greater study, but you should also first speak with your dentist or doctor before adding CBD to your regimen.

Image Credit: Jenny Friedrichs

Image Source: https://pixabay.com/photos/brushing-teeth-tooth-health-dentist-787630/

References

  1. Napimoga MH, et al. Cannabidiol decreases bone resorption by inhibiting RANK/RANKL expression and pro-inflammatory cytokines during experimental periodontitis in rats. Int Immunopharmacol. 2009; 9(2):216-222.
  2. Stahl V & Vasudevan K. Comparison of efficacy of cannabinoids versus commercial oral care products in reducing bacterial content from dental plaque: a preliminary observation. Cureus. 2020; 12(1):e6809.
  3. Russo EB. Cannabinoids in the management of difficult to treat pain. Ther Clin Risk Manag. 2008; 4(1):245-259.

Filed Under: CBD Health

Pennsylvania Governor Includes Adult-Use Cannabis Legalization in State Budget Proposal

February 4, 2021 by CBD OIL

Willie Nelson’s cannabis brand, Willie’s Reserve, has hit the Arizona market through a recently announced partnership with Hana Meds, an Arizona-based vertically integrated cannabis company.

Willie’s Reserve is a national cannabis brand inspired by cannabis activist and American music legend Willie Nelson. The brand focuses on various cannabis products like pre-rolls, flower, vape cartridges and more. 

Hana Meds is processing, packaging and distributing Willie’s Reserve pre-rolls across Hana Meds’ retail locations in Kingman and Green Valley, Ariz., and at its wholesale customer locations, Giving Tree Dispensary in Phoenix and MedMen Scottsdale, said Matt Pinchera, Hana Meds president.

“We are starting off with launching pre-rolls only, and then we’ll look at other products as it makes sense,” he said. “We definitely want to expand the product line, but right now, we’re focusing on the pre-rolls first.”

Hana Meds eventually hopes to expand the number of dispensaries the product is sold in, he said.

Courtesy of Hana Meds

Pinchera

“We are in the process of ramping up production, so, hopefully, we’ll be able to expand the wholesale customers as we expand our production capabilities,” he said. “We’ve got two dispensaries who partnered with us to launch the brand and want to make sure that we keep them in stock of a product. So, you know, we don’t want to expand too quickly. It really needs to be tied to our production increases.”

Aside from Hana Meds’ already established in-house brands, like Dutchie pre-rolls and Revival Infused Edibles, Pinchera said that Hana Meds also looks to partner with companies that acquire brands that Hana Meds feels will do well in the Arizona market. Willie’s Reserve fit the bill.

So, how did the official partnership happen?

Hana Meds met Willie’s Reserve team members at a conference in 2019, where they started to explore the partnership option and discuss Hana Meds’ capabilities.

“Because we already produce a pre-roll brand, we have the infrastructure in place to produce pre-rolls, which is what they wanted to enter the market with,” he said. “So, that lined up for them and for us. I also think the fact that we were in the process of expanding our production, which means we would be able to supply more products for Willie’s Reserve in the future, was also a positive in their eyes, from what we brought to the table.”

Pinchera believes that if a cannabis business is looking to partner with a national brand in a local market, it’s essential to highlight their own skills and growth capabilities.

“I think you need to focus on your capabilities, focus on what you do well; for us, it was producing pre-rolls with our Dutchie brand,” he said. “Secondly, anticipate growth and work on expanding production and cultivation. You really just have to leverage what you do well and make sure you have the capacity for increased production.”

For example, as Hana Meds started conversing with Willie’s Reserve, it began to expand its production facilities to ensure it could handle the increased pre-roll production, which was done to ensure Willie’s Reserve needs are met and to try and attract other brands that Hana Meds wanted to partner with, he said.

Alongside production expansion, Hana Meds also wants to consistently put a quality product out under the Willie’s Reserve name.

“The cannabis has to be high quality, which we’ve had a lot of success with our Dutchie brand,” he said. “Our wholesale customers and medical patient customers up until now have found our cannabis to be of high quality. That was certainly something that Willie’s demanded and that’s something that we’ve been producing, and we’re able to offer up to them.”

Hana Meds and Willie’s Reserve share similar values. They are dedicated to producing high-quality cannabis products, which leads Pinchera to believe that this will be a continuing partnership.

“Because they have a solid marketing department, utilizing both social media and traditional media, and because they have Willie Nelson as a brand ambassador, that has been a huge positive for us,” he said. “And I think the partnership will continue to be a huge positive for us moving forward. Willie’s Reserve has a lot to bring to the table, and they’re a great company to partner with.”

 

Filed Under: Cannabis News

  • « Go to Previous Page
  • Go to page 1
  • Interim pages omitted …
  • Go to page 74
  • Go to page 75
  • Go to page 76
  • Go to page 77
  • Go to page 78
  • Interim pages omitted …
  • Go to page 116
  • Go to Next Page »

Footer

  • Home
  • Privacy Policy
  • Terms of Service